Don't be fooled by a graph. New research shows that a scientist's policy preferences can influence their results. Look past the model and find the ground truth.

Newcastle is among the cities in the path of winter weather ...

Tesla, Inc. stock looks extremely overvalued vs. sector P/E medians; see the $42 fair-value case and 80% downside risk. Click ...

CaptivateIQ reports that while 59% of companies rely on incentives for growth, many fail to execute them effectively, ...

XRP trades 60% below ATH as institutional demand rises. Analysts map five adoption phases with targets up to $10.

Climate risk data has quietly moved from the background of real estate underwriting into the center of many residential transactions. What was ...

I counted at least 24. I leave it to your imagination how many of these will be forgotten and abandoned by next year' ...

Lindsay Owens is the executive director of the Groundwork Collaborative, a nonprofit progressive think tank that’s been ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

If you are wondering whether Sarepta Therapeutics' current share price offers value or just fresh risk, you are not alone.

Eisgruber sent his 10th annual State of the University letter, titled “From Growth to Focus,” to faculty, students and staff on Monday, Feb. 2.

Probability-based forecasts can better inform weather-based decision-making, according to new Met Office research.